Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
BACKGROUND OF THE INVENTION Field of the Invention (Technical Field): The present invention relates to a method and multiple agents for treatment of sexual dysfunction, including male erectile dysfunction, including separate and preferably sequential administration of a melanocortin 3 and/or 4 receptor agonist, such as Ac-Nle-cyc/o(-Asp-His-D-Phe- Arg-Trp-Lys)-OH (PT-141), preferably by one route of administration, such as intranasal (IN), and a type V phosphodiesterase (PDE-5) inhibitor, such as Viagra , a trademark for a brand of sildenafil, preferably by another route of administration, such as oral
Key Strengths: Key Weaknesses: Clinical research shows BPC-157 accelerates tendon healing by 60-80% compared to placebo in animal studies (Seiwerth et al., Journal of Physiology and Pharmacology, 2018)
Human LR3-IGF-1 Recombinant Protein Tag Free Lyophilized from Innovative Research has been recombinantly produced in E
On average, the drugs cost $1,540 per prescription, but patients paid an average of just under $35 out-of-pocket for each prescription
Additional Information Related Categories Write Your Own Review
US$ 21.27
US$ 21.50
US$ 26.11
US$ 22.67
US$ 22.32
